Dengue Vaccine
![Takeda Hypes Dengue Vaccine to Offset Vyvanse Loss](https://pharmtales.com/wp-content/uploads/2023/07/As-Vyvanse-generics-loom-Takeda-exaggerates-the-progress-of-the-dengue-vaccine-launch.jpg)
As Vyvanse generics loom, Takeda exaggerates the progress of the dengue vaccine launch
SG Tylor
As generics of the popular ADHD medication Vyvanse loom on the horizon, Takeda is looking to rely on newer launches ...
![Takeda withdraws its FDA application for a dengue vaccine due to data disagreements with the authority](https://pharmtales.com/wp-content/uploads/2023/07/Takeda-withdraws-its-FDA-application-for-a-dengue-vaccine-due-to-data-disagreements-with-the-authority.jpg)
Takeda withdraws its FDA application for a dengue vaccine due to data disagreements with the authority
SG Tylor
Source: Takeda Takeda announced on 11 July that it is withdrawing its application for the dengue vaccine candidate, TAK-003, from ...